ProfileGDS4718 / 222398_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 94% 93% 91% 93% 92% 98% 98% 93% 92% 93% 93% 92% 96% 97% 97% 94% 93% 96% 97% 94% 94% 94% 92% 93% 94% 97% 93% 96% 92% 97% 93% 96% 92% 91% 97% 97% 97% 93% 94% 93% 93% 97% 96% 97% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.058394
GSM549102patient 115, normal, homogenized [OPG study]9.65593
GSM549104patient 119, normal, homogenized [OPG study]9.3338891
GSM549108patient 138, normal, homogenized [OPG study]9.657193
GSM549119patient 077, normal, homogenized [OPG study]9.4961592
GSM549133patient 032, cancer, homogenized [OPG study]11.19898
GSM549139patient 042, cancer, homogenized [OPG study]11.110898
GSM549099patient 107, normal, homogenized [OPG study]9.7861893
GSM549109patient 139, normal, homogenized [OPG study]9.6808192
GSM549110patient 046, normal, homogenized [OPG study]9.8356693
GSM549114patient 063, normal, homogenized [OPG study]9.9740793
GSM549122patient 082, normal, homogenized [OPG study]9.6376792
GSM549134patient 033, cancer, homogenized [OPG study]10.550796
GSM549136patient 036, cancer, homogenized [OPG study]10.767897
GSM549140patient 044, cancer, homogenized [OPG study]10.777397
GSM549111patient 047, normal, homogenized [OPG study]10.14994
GSM549113patient 057, normal, homogenized [OPG study]10.060993
GSM549132patient 031, cancer, homogenized [OPG study]10.516996
GSM549137patient 038, cancer, homogenized [OPG study]10.663697
GSM549142patient 047, cancer, homogenized [OPG study]9.3631594
GSM549100patient 110, normal, homogenized [OPG study]9.8933594
GSM549107patient 135, normal, homogenized [OPG study]10.009194
GSM549115patient 068, normal, homogenized [OPG study]9.7634792
GSM549116patient 072, normal, homogenized [OPG study]9.8292893
GSM549120patient 078, normal, homogenized [OPG study]10.020594
GSM549131patient 030, cancer, homogenized [OPG study]10.802897
GSM549118patient 074, normal, homogenized [OPG study]9.8670593
GSM549129patient 027, cancer, homogenized [OPG study]10.266696
GSM549123patient 088, normal, homogenized [OPG study]9.5911492
GSM549124patient 006, cancer, homogenized [OPG study]10.756297
GSM549126patient 015, cancer, homogenized [OPG study]9.6500493
GSM549128patient 025, cancer, homogenized [OPG study]10.40696
GSM549103patient 117, normal, homogenized [OPG study]9.5459192
GSM549117patient 073, normal, homogenized [OPG study]9.5476191
GSM549138patient 041, cancer, homogenized [OPG study]10.91297
GSM549141patient 045, cancer, homogenized [OPG study]11.03397
GSM549130patient 028, cancer, homogenized [OPG study]10.554997
GSM549101patient 111, normal, homogenized [OPG study]9.7748393
GSM549105patient 128, normal, homogenized [OPG study]9.950694
GSM549106patient 134, normal, homogenized [OPG study]9.8870493
GSM549112patient 048, normal, homogenized [OPG study]9.9603693
GSM549125patient 011, cancer, homogenized [OPG study]10.62697
GSM549127patient 024, cancer, homogenized [OPG study]10.250896
GSM549135patient 035, cancer, homogenized [OPG study]10.984297